Multi-center MRD Registry for Inflammatory Breast Cancer
Sponsored by M.D. Anderson Cancer Center
About this study
To collect data from participants with IBC who may have had MRD testing and may have surgery in the future.
Primary Objectives -To determine the incidence of protocol specified pre-surgery MRD-positivity in IBC (assessment between completion of planned systemic therapy and surgery). Secondary Objectives * To establish the feasibility of multi-institutional MRD data collection using standard of care Signatera analysis in IBC participants. * To evaluate the association of pre-surgery MRD to pathologic response. * To evaluate participant reported QOL for worry about recurrence based in participants receiving MRD results * To establish protocol-optional baseline and longitudinal MRD data collection in IBC participants and report the frequency of MRD longitudinally * To determine the median lead time between the first MRD-positive result and clinical recurrence. * To determine whether adjuvant the…
Where this study is enrolling
- I'm interested
MD Anderson Cancer Center
Houston, Texas
Who can participate
Inclusion criteria
- ✓Female or males ≥18 years of age with the ability to understand and sign a written
- ✓Participants who have a clinical diagnosis of stage III or IV inflammatory breast cancer (IBC).
- ✓Participants who are planning to have or already completed a minimum of one blood draw for Signatera testing, for which the result and clinical data can be deposited into the study database.
- ✓Participants must be within eight months of diagnosis and have not undergone breast surgery for this diagnosis of breast cancer.
- ✓Participants must be English-speaking.
Only the research team can confirm whether you qualify. The intake questionnaire is the best way to find out.
Completing a questionnaire on Clinably does not enroll you in a clinical trial or confirm your eligibility. Only the research team can determine whether you qualify to participate. These results are based on the information you provide and are intended to help you start a conversation with the research team.
Trial data sourced from ClinicalTrials.gov.